Click for best price
RSV Vaccine Market Size, Share 2024
The global RSV Vaccine market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Clinical I Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of RSV Vaccine include Pfizer, GSK, Moderna, JNJ, Bavarian Nordic, Nuance Pharma and Advaccine, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for RSV Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RSV Vaccine. This report contains market size and forecasts of RSV Vaccine in global, including the following market information:
Global RSV Vaccine Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global RSV Vaccine Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five RSV Vaccine companies in 2023 (%)
We surveyed the RSV Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global RSV Vaccine Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global RSV Vaccine Market Segment Percentages, by Type, 2023 (%)
Clinical I
Clinical II
Clinical III
Preclinical
Being Developed
Global RSV Vaccine Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global RSV Vaccine Market Segment Percentages, by Application, 2023 (%)
Elderly Vaccine
Infant Vaccine
Others
Global RSV Vaccine Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global RSV Vaccine Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies RSV Vaccine revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies RSV Vaccine revenues share in global market, 2023 (%)
Key companies RSV Vaccine sales in global market, 2019-2024 (Estimated), (K Units)
Key companies RSV Vaccine sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
GSK
Moderna
JNJ
Bavarian Nordic
Nuance Pharma
Advaccine
Outline of Major Chapters:
Chapter 1: Introduces the definition of RSV Vaccine, market overview.
Chapter 2: Global RSV Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of RSV Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of RSV Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global RSV Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
RSV Vaccine Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
72 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 RSV Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global RSV Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global RSV Vaccine Overall Market Size
2.1 Global RSV Vaccine Market Size: 2023 VS 2030
2.2 Global RSV Vaccine Revenue, Prospects & Forecasts: 2019-2030
2.3 Global RSV Vaccine Sales: 2019-2030
3 Company Landscape
3.1 Top RSV Vaccine Players in Global Market
3.2 Top Global RSV Vaccine Companies Ranked by Revenue
3.3 Global RSV Vaccine Revenue by Companies
3.4 Global RSV Vaccine Sales by Companies
3.5 Global RSV Vaccine Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 RSV Vaccine Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers RSV Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 RSV Vaccine Players in Global Market
3.8.1 List of Global Tier 1 RSV Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 RSV Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global RSV Vaccine Market Size Markets, 2023 & 2030
4.1.2 Clinical I
4.1.3 Clinical II
4.1.4 Clinical III
4.1.5 Preclinical
4.1.6 Being Developed
4.2 By Type - Global RSV Vaccine Revenue & Forecasts
4.2.1 By Type - Global RSV Vaccine Revenue, 2019-2024
4.2.2 By Type - Global RSV Vaccine Revenue, 2025-2030
4.2.3 By Type - Global RSV Vaccine Revenue Market Share, 2019-2030
4.3 By Type - Global RSV Vaccine Sales & Forecasts
4.3.1 By Type - Global RSV Vaccine Sales, 2019-2024
4.3.2 By Type - Global RSV Vaccine Sales, 2025-2030
4.3.3 By Type - Global RSV Vaccine Sales Market Share, 2019-2030
4.4 By Type - Global RSV Vaccine Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global RSV Vaccine Market Size, 2023 & 2030
5.1.2 Elderly Vaccine
5.1.3 Infant Vaccine
5.1.4 Others
5.2 By Application - Global RSV Vaccine Revenue & Forecasts
5.2.1 By Application - Global RSV Vaccine Revenue, 2019-2024
5.2.2 By Application - Global RSV Vaccine Revenue, 2025-2030
5.2.3 By Application - Global RSV Vaccine Revenue Market Share, 2019-2030
5.3 By Application - Global RSV Vaccine Sales & Forecasts
5.3.1 By Application - Global RSV Vaccine Sales, 2019-2024
5.3.2 By Application - Global RSV Vaccine Sales, 2025-2030
5.3.3 By Application - Global RSV Vaccine Sales Market Share, 2019-2030
5.4 By Application - Global RSV Vaccine Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global RSV Vaccine Market Size, 2023 & 2030
6.2 By Region - Global RSV Vaccine Revenue & Forecasts
6.2.1 By Region - Global RSV Vaccine Revenue, 2019-2024
6.2.2 By Region - Global RSV Vaccine Revenue, 2025-2030
6.2.3 By Region - Global RSV Vaccine Revenue Market Share, 2019-2030
6.3 By Region - Global RSV Vaccine Sales & Forecasts
6.3.1 By Region - Global RSV Vaccine Sales, 2019-2024
6.3.2 By Region - Global RSV Vaccine Sales, 2025-2030
6.3.3 By Region - Global RSV Vaccine Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America RSV Vaccine Revenue, 2019-2030
6.4.2 By Country - North America RSV Vaccine Sales, 2019-2030
6.4.3 US RSV Vaccine Market Size, 2019-2030
6.4.4 Canada RSV Vaccine Market Size, 2019-2030
6.4.5 Mexico RSV Vaccine Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe RSV Vaccine Revenue, 2019-2030
6.5.2 By Country - Europe RSV Vaccine Sales, 2019-2030
6.5.3 Germany RSV Vaccine Market Size, 2019-2030
6.5.4 France RSV Vaccine Market Size, 2019-2030
6.5.5 U.K. RSV Vaccine Market Size, 2019-2030
6.5.6 Italy RSV Vaccine Market Size, 2019-2030
6.5.7 Russia RSV Vaccine Market Size, 2019-2030
6.5.8 Nordic Countries RSV Vaccine Market Size, 2019-2030
6.5.9 Benelux RSV Vaccine Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia RSV Vaccine Revenue, 2019-2030
6.6.2 By Region - Asia RSV Vaccine Sales, 2019-2030
6.6.3 China RSV Vaccine Market Size, 2019-2030
6.6.4 Japan RSV Vaccine Market Size, 2019-2030
6.6.5 South Korea RSV Vaccine Market Size, 2019-2030
6.6.6 Southeast Asia RSV Vaccine Market Size, 2019-2030
6.6.7 India RSV Vaccine Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America RSV Vaccine Revenue, 2019-2030
6.7.2 By Country - South America RSV Vaccine Sales, 2019-2030
6.7.3 Brazil RSV Vaccine Market Size, 2019-2030
6.7.4 Argentina RSV Vaccine Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa RSV Vaccine Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa RSV Vaccine Sales, 2019-2030
6.8.3 Turkey RSV Vaccine Market Size, 2019-2030
6.8.4 Israel RSV Vaccine Market Size, 2019-2030
6.8.5 Saudi Arabia RSV Vaccine Market Size, 2019-2030
6.8.6 UAE RSV Vaccine Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer RSV Vaccine Major Product Offerings
7.1.4 Pfizer RSV Vaccine Sales and Revenue in Global (2019-2024)
7.1.5 Pfizer Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK RSV Vaccine Major Product Offerings
7.2.4 GSK RSV Vaccine Sales and Revenue in Global (2019-2024)
7.2.5 GSK Key News & Latest Developments
7.3 Moderna
7.3.1 Moderna Company Summary
7.3.2 Moderna Business Overview
7.3.3 Moderna RSV Vaccine Major Product Offerings
7.3.4 Moderna RSV Vaccine Sales and Revenue in Global (2019-2024)
7.3.5 Moderna Key News & Latest Developments
7.4 JNJ
7.4.1 JNJ Company Summary
7.4.2 JNJ Business Overview
7.4.3 JNJ RSV Vaccine Major Product Offerings
7.4.4 JNJ RSV Vaccine Sales and Revenue in Global (2019-2024)
7.4.5 JNJ Key News & Latest Developments
7.5 Bavarian Nordic
7.5.1 Bavarian Nordic Company Summary
7.5.2 Bavarian Nordic Business Overview
7.5.3 Bavarian Nordic RSV Vaccine Major Product Offerings
7.5.4 Bavarian Nordic RSV Vaccine Sales and Revenue in Global (2019-2024)
7.5.5 Bavarian Nordic Key News & Latest Developments
7.6 Nuance Pharma
7.6.1 Nuance Pharma Company Summary
7.6.2 Nuance Pharma Business Overview
7.6.3 Nuance Pharma RSV Vaccine Major Product Offerings
7.6.4 Nuance Pharma RSV Vaccine Sales and Revenue in Global (2019-2024)
7.6.5 Nuance Pharma Key News & Latest Developments
7.7 Advaccine
7.7.1 Advaccine Company Summary
7.7.2 Advaccine Business Overview
7.7.3 Advaccine RSV Vaccine Major Product Offerings
7.7.4 Advaccine RSV Vaccine Sales and Revenue in Global (2019-2024)
7.7.5 Advaccine Key News & Latest Developments
8 Global RSV Vaccine Production Capacity, Analysis
8.1 Global RSV Vaccine Production Capacity, 2019-2030
8.2 RSV Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global RSV Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 RSV Vaccine Supply Chain Analysis
10.1 RSV Vaccine Industry Value Chain
10.2 RSV Vaccine Upstream Market
10.3 RSV Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 RSV Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of RSV Vaccine in Global Market
Table 2. Top RSV Vaccine Players in Global Market, Ranking by Revenue (2023)
Table 3. Global RSV Vaccine Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global RSV Vaccine Revenue Share by Companies, 2019-2024
Table 5. Global RSV Vaccine Sales by Companies, (K Units), 2019-2024
Table 6. Global RSV Vaccine Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers RSV Vaccine Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers RSV Vaccine Product Type
Table 9. List of Global Tier 1 RSV Vaccine Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 RSV Vaccine Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global RSV Vaccine Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global RSV Vaccine Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global RSV Vaccine Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global RSV Vaccine Sales (K Units), 2019-2024
Table 15. By Type - Global RSV Vaccine Sales (K Units), 2025-2030
Table 16. By Application ? Global RSV Vaccine Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global RSV Vaccine Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global RSV Vaccine Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global RSV Vaccine Sales (K Units), 2019-2024
Table 20. By Application - Global RSV Vaccine Sales (K Units), 2025-2030
Table 21. By Region ? Global RSV Vaccine Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global RSV Vaccine Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global RSV Vaccine Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global RSV Vaccine Sales (K Units), 2019-2024
Table 25. By Region - Global RSV Vaccine Sales (K Units), 2025-2030
Table 26. By Country - North America RSV Vaccine Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America RSV Vaccine Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America RSV Vaccine Sales, (K Units), 2019-2024
Table 29. By Country - North America RSV Vaccine Sales, (K Units), 2025-2030
Table 30. By Country - Europe RSV Vaccine Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe RSV Vaccine Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe RSV Vaccine Sales, (K Units), 2019-2024
Table 33. By Country - Europe RSV Vaccine Sales, (K Units), 2025-2030
Table 34. By Region - Asia RSV Vaccine Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia RSV Vaccine Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia RSV Vaccine Sales, (K Units), 2019-2024
Table 37. By Region - Asia RSV Vaccine Sales, (K Units), 2025-2030
Table 38. By Country - South America RSV Vaccine Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America RSV Vaccine Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America RSV Vaccine Sales, (K Units), 2019-2024
Table 41. By Country - South America RSV Vaccine Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa RSV Vaccine Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa RSV Vaccine Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa RSV Vaccine Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa RSV Vaccine Sales, (K Units), 2025-2030
Table 46. Pfizer Company Summary
Table 47. Pfizer RSV Vaccine Product Offerings
Table 48. Pfizer RSV Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Pfizer Key News & Latest Developments
Table 50. GSK Company Summary
Table 51. GSK RSV Vaccine Product Offerings
Table 52. GSK RSV Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. GSK Key News & Latest Developments
Table 54. Moderna Company Summary
Table 55. Moderna RSV Vaccine Product Offerings
Table 56. Moderna RSV Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Moderna Key News & Latest Developments
Table 58. JNJ Company Summary
Table 59. JNJ RSV Vaccine Product Offerings
Table 60. JNJ RSV Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. JNJ Key News & Latest Developments
Table 62. Bavarian Nordic Company Summary
Table 63. Bavarian Nordic RSV Vaccine Product Offerings
Table 64. Bavarian Nordic RSV Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Bavarian Nordic Key News & Latest Developments
Table 66. Nuance Pharma Company Summary
Table 67. Nuance Pharma RSV Vaccine Product Offerings
Table 68. Nuance Pharma RSV Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Nuance Pharma Key News & Latest Developments
Table 70. Advaccine Company Summary
Table 71. Advaccine RSV Vaccine Product Offerings
Table 72. Advaccine RSV Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Advaccine Key News & Latest Developments
Table 74. RSV Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 75. Global RSV Vaccine Capacity Market Share of Key Manufacturers, 2022-2024
Table 76. Global RSV Vaccine Production by Region, 2019-2024 (K Units)
Table 77. Global RSV Vaccine Production by Region, 2025-2030 (K Units)
Table 78. RSV Vaccine Market Opportunities & Trends in Global Market
Table 79. RSV Vaccine Market Drivers in Global Market
Table 80. RSV Vaccine Market Restraints in Global Market
Table 81. RSV Vaccine Raw Materials
Table 82. RSV Vaccine Raw Materials Suppliers in Global Market
Table 83. Typical RSV Vaccine Downstream
Table 84. RSV Vaccine Downstream Clients in Global Market
Table 85. RSV Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. RSV Vaccine Segment by Type in 2023
Figure 2. RSV Vaccine Segment by Application in 2023
Figure 3. Global RSV Vaccine Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global RSV Vaccine Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global RSV Vaccine Revenue, 2019-2030 (US$, Mn)
Figure 7. RSV Vaccine Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by RSV Vaccine Revenue in 2023
Figure 9. By Type - Global RSV Vaccine Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global RSV Vaccine Revenue Market Share, 2019-2030
Figure 11. By Type - Global RSV Vaccine Sales Market Share, 2019-2030
Figure 12. By Type - Global RSV Vaccine Price (US$/Unit), 2019-2030
Figure 13. By Application - Global RSV Vaccine Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global RSV Vaccine Revenue Market Share, 2019-2030
Figure 15. By Application - Global RSV Vaccine Sales Market Share, 2019-2030
Figure 16. By Application - Global RSV Vaccine Price (US$/Unit), 2019-2030
Figure 17. By Region - Global RSV Vaccine Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global RSV Vaccine Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global RSV Vaccine Revenue Market Share, 2019-2030
Figure 20. By Region - Global RSV Vaccine Sales Market Share, 2019-2030
Figure 21. By Country - North America RSV Vaccine Revenue Market Share, 2019-2030
Figure 22. By Country - North America RSV Vaccine Sales Market Share, 2019-2030
Figure 23. US RSV Vaccine Revenue, (US$, Mn), 2019-2030
Figure 24. Canada RSV Vaccine Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico RSV Vaccine Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe RSV Vaccine Revenue Market Share, 2019-2030
Figure 27. By Country - Europe RSV Vaccine Sales Market Share, 2019-2030
Figure 28. Germany RSV Vaccine Revenue, (US$, Mn), 2019-2030
Figure 29. France RSV Vaccine Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. RSV Vaccine Revenue, (US$, Mn), 2019-2030
Figure 31. Italy RSV Vaccine Revenue, (US$, Mn), 2019-2030
Figure 32. Russia RSV Vaccine Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries RSV Vaccine Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux RSV Vaccine Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia RSV Vaccine Revenue Market Share, 2019-2030
Figure 36. By Region - Asia RSV Vaccine Sales Market Share, 2019-2030
Figure 37. China RSV Vaccine Revenue, (US$, Mn), 2019-2030
Figure 38. Japan RSV Vaccine Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea RSV Vaccine Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia RSV Vaccine Revenue, (US$, Mn), 2019-2030
Figure 41. India RSV Vaccine Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America RSV Vaccine Revenue Market Share, 2019-2030
Figure 43. By Country - South America RSV Vaccine Sales Market Share, 2019-2030
Figure 44. Brazil RSV Vaccine Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina RSV Vaccine Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa RSV Vaccine Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa RSV Vaccine Sales Market Share, 2019-2030
Figure 48. Turkey RSV Vaccine Revenue, (US$, Mn), 2019-2030
Figure 49. Israel RSV Vaccine Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia RSV Vaccine Revenue, (US$, Mn), 2019-2030
Figure 51. UAE RSV Vaccine Revenue, (US$, Mn), 2019-2030
Figure 52. Global RSV Vaccine Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production RSV Vaccine by Region, 2023 VS 2030
Figure 54. RSV Vaccine Industry Value Chain
Figure 55. Marketing Channels
